Rate of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes Can Be Predicted from Glycemic Variability Data
- 1 November 2012
- journal article
- research article
- Published by Mary Ann Liebert Inc in Diabetes Technology & Therapeutics
- Vol. 14 (11), 1008-1012
- https://doi.org/10.1089/dia.2012.0099
Abstract
Background: We set out to study the relationship between different measures of glycemic variability and the rate of hypoglycemia in patients with type 2 diabetes. Subjects and Methods: Data were pooled from three 24-week insulin trials including patients on twice-daily (BID) insulin lispro mix 75/25 (75% insulin lispro protamine suspension, 25% insulin lispro) (n=805), daily (QD) insulin glargine (n=1,019), insulin lispro protamine suspension (n=353) (QD or BID), and insulin detemir (n=166) (QD or BID), all with continuation of prestudy oral antihyperglycemic medications. Glycemic variability measures were derived from seven-point self-monitored blood glucose profiles. Results: At baseline, mean (±SD) age was 56.9±9.7 years, duration of type 2 diabetes was 9.5±6.1 years, hemoglobin A1c (HbA1c) was 8.9±1.1%, and 51.9% were male. Intra-day glucose coefficient of variation (CV), fasting blood glucose, intra-day minimum glucose and inter-day glucose CV at 24 weeks, and intra-day glucose CV at baseline were significantly correlated with the rate of hypoglycemia events between Weeks 12 to 24 (PConclusions: Intra-day and inter-day glycemic variability is significantly associated with the risk of hypoglycemia in insulin-treated patients with type 2 diabetes, even after adjusting for mean glucose and HbA1c. The intra-day glycemic variability before starting insulin is significantly associated with the risk of hypoglycemia during insulin treatment, which points at treatment- and patient-related factors mediating this relationship.Keywords
This publication has 15 references indexed in Scilit:
- The Contribution of Glucose Variability to Asymptomatic Hypoglycemia in Persons with Type 2 DiabetesDiabetes Technology & Therapeutics, 2011
- Addition of insulin lispro protamine suspension or insulin glargine to oral type 2 diabetes regimens: a randomized trialDiabetes, Obesity and Metabolism, 2010
- Glucose Variability; Does It Matter?Endocrine Reviews, 2010
- A randomized, treat‐to‐target trial comparing insulin lispro protamine suspension and insulin detemir in insulin‐naive patients with Type 2 diabetesDiabetic Medicine, 2010
- DURAbility of Basal Versus Lispro Mix 75/25 Insulin Efficacy (DURABLE) Trial 24-Week ResultsDiabetes Care, 2009
- Relating mean blood glucose and glucose variability to the risk of multiple episodes of hypoglycaemia in type 1 diabetesDiabetologia, 2007
- Evaluation of a New Measure of Blood Glucose Variability in DiabetesDiabetes Care, 2006
- A Probabilistic Model for Predicting Hypoglycemia in Type 2 Diabetes MellitusArchives of Internal Medicine, 2004
- Frequency of severe hypoglycemia in insulin-dependent diabetes mellitus can be predicted from self-monitoring blood glucose dataJournal of Clinical Endocrinology & Metabolism, 1994
- Mean Amplitude of Glycemic Excursions, a Measure of Diabetic InstabilityDiabetes, 1970